EE94 Cost-Effectiveness Analysis of Vaccinating Against Herpes Zoster With Adjuvanted Recombinant Zoster Vaccine in Switzerland

Saved in:
Bibliographic Details
Published in:Value in health 2022-12, Vol.25 (12), p.S71-S71
Main Authors: Nishimwe, ML, Fischer, L, Kientsch, U, Giannelos, N
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.346